Skip to main content

Table 1 Baseline characteristics of participants

From: Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population

Group Control SA UA AMI P
N 103 190 293 195  
Age (years) 60.57 ± 9.57 62.77 ± 10.68 64.70 ± 10.83 61.79 ± 11.84 0.002
Male (%) 67(65.0) 154 (81.1) 225(76.8) 159(81.5) 0.006
Family history (%) 8(7.8) 12 (6.3) 12(4.1) 6(3.1) 0.216
Smoking (%) 25(24.3) 73 (38.4) 105(35.8) 87(44.6) 0.006
Hypertension (%) 67(65.0) 108 (56.8) 191(65.2) 103(52.8) 0.025
Diabetes mellitus (%) 24(23.3) 61 (32.1) 93(31.7) 60(30.8) 0.396
FBG (mmol/L)* 5.41 (3.78-13.64) 5.64 (5.06-6.94) 5.74(4.97-7.49) 5.85(4.92-8.22) 0.148
HbA1c (%) 6.33 ± 1.59 6.50 ± 1.37 6.44 ± 1.25 6.48 ± 1.38 0.727
Lp(a)(mmol/L)* 96.05 (27.06-158.56) 130.15 (66.79-293.25) 172.97(82.43-420.94) 176.97(101.09-289.26) < 0.001
TC(mmol/L) 4.54 ± 1.07 4.29 ± 1.01 4.41 ± 1.22 4.43 ± 1.08 0.316
TG(mmol/L) 1.74 ± 1.40 1.59 ± 0.97 1.60 ± 0.95 1.64 ± 1.13 0.792
LDL-C (mmol/L) 2.72 ± 0.89 2.57 ± 0.86 2.67 ± 0.98 2.79 ± 0.91 0.263
HDL-C (mmol/L) 1.08 ± 0.26 1.02 ± 0.27 1.00 ± 0.25 0.90 ± 0.17 < 0.001
apoA(mmol/L) 1.18 ± 0.24 1.14 ± 0.32 1.10 ± 0.25 0.98 ± 0.20 < 0.001
apoB(mmol/L) 0.81 ± 0.18 0.77 ± 0.19 0.80 ± 0.22 0.85 ± 0.28 0.071
Lp-PLA2 (μg/L)* 7.37 (2.34-15.78) 5.94(2.89-8.55) 8.56(5.34-11.95) 8.68(5.56-13.27) < 0.001
  1. Denote: *indicated median and inter-quartile range, FBG = fasting blood glucose, HbA1c = glycated hemoglobin, Lp(a) = lipoprotein (a), TC = total cholesterol, TG = triglyceride, LDL-C = low density lipoprotein-cholesterol, HDL-C = high density lipoprotein-cholesterol, apoA = apoprotein A, apoB = apoprotein B, Lp-PLA2 = lipoprotein associated-phospholipase A2.